Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Clinical Investigation|March 23, 2023
Durability of immune responses to mRNA booster vaccination against COVID-19Prabhu S Arunachalam, Lilin Lai, Hady Samaha, et al.Science Immunology|April 5, 2024
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humansLilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.Vaccine|March 21, 2026
Intranasal PIV5-vectored SARS-COV-2 KP.2 vaccine protects against homologous and heterologous challenge in mice and hamstersKelsey Briggs, Maria Cristina Gingerich, Aaron Gingerich, et al.Blood Cancer Discovery|December 13, 2022
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough InfectionsMaryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, et al.Nature Communications|August 12, 2024
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.Science Translational Medicine|September 3, 2025
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteinsSanjeev Kumar, Shilpi Jain, Bushra Wali, et al.Biorxiv : the Preprint Server for Biology|November 21, 2023
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.Pageof 4